pcDNA3.1-N-Myc_535-888 USP7
(Plasmid
#131248)
-
PurposeMammalian expression of the USP7 UBL1-3 domains with an N-terminal Myc tag.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 131248 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1+/N-Myc
-
Backbone manufacturerGenscript
- Backbone size w/o insert (bp) 5435
- Total vector size (bp) 7154
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameUbiquitin carboxyl-terminal hydrolase 7
-
Alt nameUbiquitin-specific-processing protease 7
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1719
-
MutationA mutant form of our pcDNA3.1-N-Myc_535-1102 USP7 plasmid (Addgene plasmid 131246), where the codon for E889 was converted to a STOP codon. This mutation limits expression to UBLs 1 - 3
-
Entrez GeneUSP7 (a.k.a. C16DELp13.2, DEL16P13.2, HAFOUS, HAUSP, TEF1)
-
Tag
/ Fusion Protein
- Myc (N terminal on backbone)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-N-Myc_535-888 USP7 was a gift from Roger Woodgate (Addgene plasmid # 131248 ; http://n2t.net/addgene:131248 ; RRID:Addgene_131248) -
For your References section:
DNA Polymerase iota Interacts with Both the TRAF-like and UBL1-2 Domains of USP7. Ashton NW, Valles GJ, Jaiswal N, Bezsonova I, Woodgate R. J Mol Biol. 2021 Jan 22;433(2):166733. doi: 10.1016/j.jmb.2020.166733. Epub 2020 Dec 3. 10.1016/j.jmb.2020.166733 PubMed 33279577